| Secondary |
| Drug Use For Unknown Indication |
21.6% |
| Non-small Cell Lung Cancer |
13.8% |
| Product Used For Unknown Indication |
7.8% |
| Lung Neoplasm Malignant |
6.0% |
| Breast Disorder |
4.8% |
| Depression |
4.8% |
| Ovarian Cancer |
4.8% |
| Breast Cancer |
4.2% |
| Non-hodgkin's Lymphoma |
3.6% |
| Hypertension |
3.0% |
| Inflammatory Carcinoma Of The Breast |
3.0% |
| Mantle Cell Lymphoma |
3.0% |
| Nausea |
3.0% |
| Abdominal Pain Upper |
2.4% |
| Breast Cancer Female |
2.4% |
| Colorectal Cancer Metastatic |
2.4% |
| Epilepsy |
2.4% |
| Ex-smoker |
2.4% |
| Gastrointestinal Carcinoma |
2.4% |
| Gastrooesophageal Reflux Disease |
2.4% |
|
| Weight Decreased |
12.0% |
| White Blood Cell Count Decreased |
8.0% |
| Cognitive Disorder |
6.0% |
| Fatigue |
6.0% |
| Nystagmus |
6.0% |
| Pelvic Mass |
6.0% |
| Plasmacytoma |
6.0% |
| Vomiting |
6.0% |
| Gastrointestinal Carcinoma |
4.0% |
| Hepatitis B |
4.0% |
| Infection |
4.0% |
| Malaise |
4.0% |
| Osteonecrosis |
4.0% |
| Pain |
4.0% |
| Pneumonia |
4.0% |
| Renal Failure |
4.0% |
| Sepsis |
4.0% |
| Weight Increased |
4.0% |
| Brain Abscess |
2.0% |
| Drug Ineffective |
2.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
13.8% |
| Rhabdomyosarcoma |
13.8% |
| Ill-defined Disorder |
7.7% |
| Breast Cancer |
6.5% |
| Non-hodgkin's Lymphoma |
4.6% |
| Operative Haemorrhage |
4.6% |
| Pain |
4.6% |
| Colorectal Cancer |
4.2% |
| Diabetes Mellitus |
4.2% |
| Bronchopulmonary Aspergillosis |
3.8% |
| Lymphoma |
3.8% |
| Premedication |
3.8% |
| B-cell Lymphoma |
3.5% |
| Neoplasm Malignant |
3.5% |
| Non-small Cell Lung Cancer |
3.5% |
| Nuclear Magnetic Resonance Imaging |
3.5% |
| Fungal Infection |
2.7% |
| Neuralgia |
2.7% |
| Smoking Cessation Therapy |
2.7% |
| Aspergillosis |
2.3% |
|
| Respiratory Failure |
19.7% |
| Death |
9.1% |
| Hypertriglyceridaemia |
6.1% |
| Weight Increased |
6.1% |
| Eye Infection |
4.5% |
| Herpes Zoster |
4.5% |
| Ischaemic Cerebral Infarction |
4.5% |
| Metastases To Bone |
4.5% |
| Pulmonary Hypoplasia |
4.5% |
| Pyrexia |
4.5% |
| Somnolence |
4.5% |
| Convulsion |
3.0% |
| Dermatitis |
3.0% |
| Drug Ineffective |
3.0% |
| Epilepsy |
3.0% |
| Hypertension |
3.0% |
| Interstitial Lung Disease |
3.0% |
| Leukopenia |
3.0% |
| Lung Disorder |
3.0% |
| Macular Degeneration |
3.0% |
|
| Interacting |
| Neoplasm Malignant |
37.5% |
| Hiv Infection |
25.0% |
| Breast Cancer |
12.5% |
| Partial Seizures |
12.5% |
| Smoking Cessation Therapy |
12.5% |
|
| Malignant Neoplasm Progression |
20.0% |
| Throat Cancer |
20.0% |
| Visual Field Defect |
20.0% |
| Vomiting |
20.0% |
| Walking Aid User |
20.0% |
|
